Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload

Physiological Reports

Volumn 3, Issue 8, 2015, Pages

  Holzem, Katherine M ^a   Marmerstein, Joseph T ^a   Madden, Eli J ^a   Efimov, Igor R ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Diet induced obesity; Electrophysiology; Heart failure; Hypertrophy; Remodeling; Signaling

Indexed keywords

KETAMINE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DIET INDUCED OBESITY; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FLUORESCENCE IMAGING; FOLLOW UP; HEART LEFT VENTRICLE OVERLOAD; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC DYSFUNCTION; VASCULAR REMODELING;

EID: 84953419192     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12489     Document Type: Article

References (61)

1. Akar, F. G., D. D. Spragg, R. S. Tunin, D. A. Kass, and G. F. Tomaselli. 2004. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ. Res. 95:717-725.
2. Akar, F. G., R. D. Nass, S. Hahn, E. Cingolani, M. Shah, G. G. Hesketh, et al. 2007. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am. J. Physiol. Heart Circ. Physiol. 293:H1223-H1230.
3. Artham, S. M., C. J. Lavie, H. M. Patel, and H. O. Ventura. 2008. Impact of obesity on the risk of heart failure and its prognosis. J. Cardiometab. Syndr. 3:155-161.
4. Auger-Messier, M., F. Accornero, S. A. Goonasekera, O. F. Bueno, J. N. Lorenz, J. H. van Berlo, et al. 2013. Unrestrained p38 MAPK activation in dusp1/4 double-null mice induces cardiomyopathy. Circ. Res. 112:48-56.
5. Badheka, A. O., A. Rathod, M. A. Kizilbash, N. Garg, T. Mohamad, L. Afonso, et al. 2010. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am. J. Med. 123:646-651.
6. Chambers, J. W., A. Pachori, S. Howard, S. Iqbal, and P. V. LoGrasso. 2013. Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats. J. Biol. Chem. 288:4000-4011.
7. Chess, D. J., and W. C. Stanley. 2008. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc. Res. 79:269-278.
8. Chess, D. J., B. Lei, B. D. Hoit, A. M. Azimzadeh, and W. C. Stanley. 2007. Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload. Am. J. Physiol. Heart Circ. Physiol. 293:H1853-H1860.
9. Chess, D. J., B. Lei, B. D. Hoit, A. M. Azimzadeh, and W. C. Stanley. 2008. Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. J. Card. Fail. 14:82-88.
10. Chokshi, A., K. Drosatos, F. H. Cheema, R. Ji, T. Khawaja, S. Yu, et al. 2012. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125:2844-2853.
11. Choukroun, G., R. Hajjar, S. Fry, F. del Monte, S. Haq, J. L. Guerrero, et al. 1999. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases. J. Clin. Invest. 104:391-398.
12. Chu, C.-H., B.-S. Tzang, L.-M. Chen, C.-J. Liu, F.-J. Tsai, C.-H. Tsai, et al. 2009. Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through Gaq and downstream calcineurin signaling in myocardial cells. Endocrinology 150:2723-2731.
13. DeBosch, B., I. Treskov, T. S. Lupu, C. Weinheimer, A. Kovacs, M. Courtois, et al. 2006. Akt1 is required for physiological cardiac growth. Circulation 113:2097-2104.
14. Dou, Y., P. Arlock, and A. Arner. 2007. Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle. Am. J. Physiol. Cell Physiol. 293:C1148-C1153.
15. Duda, M. K., K. M. O’Shea, B. Lei, B. R. Barrows, A. M. Azimzadeh, T. E. McElfresh, et al. 2008. Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J. Card. Fail. 14:327-335.
16. Esposito, G., S. V. N. Prasad, A. Rapacciuolo, L. Mao, W. J. Koch, and H. A. Rockman. 2001. Cardiac overexpression of a Gq inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activity in in vivo pressure overload. Circulation 103:1453-1458.
17. Felker, G. M., M. Fiuzat, L. K. Shaw, R. Clare, D. J. Whellan, L. Bettari, et al. 2012. Galectin-3 in ambulatory patients with heart failure results from the HF-ACTION study. Circulation. Heart failure. 5:72-78.
18. Glukhov, A. V., T. P. Flagg, V. V. Fedorov, I. R. Efimov, and C. G. Nichols. 2010. Differential K(ATP) channel pharmacology in intact mouse heart. J. Mol. Cell. Cardiol. 48:152-160.
19. Glukhov, A. V., V. V. Fedorov, P. W. Kalish, V. K. Ravikumar, Q. Lou, D. Janks, et al. 2012. Conduction remodeling in human end-stage non-ischemic left ventricular cardiomyopathy. Circulation 125:1835-1847.
20. Guh, D. P., W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis. 2009. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88.
21. Han, M. S., D. Y. Jung, C. Morel, S. A. Lakhani, J. K. Kim, R. A. Flavell, et al. 2013. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339:218-222.
22. Hasenfuss, G. 1998. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc. Res. 39:60-76.
23. Hill, A. B. 1965. The environment and disease: association or causation? Proc. R. Soc. Med. 58:295-300.
24. Hirosumi, J., G. Tuncman, L. Chang, C. Z. Görgün, K. T. Uysal, K. Maeda, et al. 2002. A central role for JNK in obesity and insulin resistance. Nature 420:333-336.
25. Houser, S. R., K. B. Margulies, A. M. Murphy, F. G. Spinale, G. S. Francis, S. D. Prabhu, et al. 2012. Animal models of heart failure: a scientific statement from the American Heart Association. Circ. Res. 111:131-150.
26. Jagasia, D., J. M. Whiting, J. Concato, S. Pfau, and P. H. McNulty. 2001. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease. Circulation 103:1734-1739.
27. Kaiser, R. A., Q. R. Liang, O. Bueno, Y. Huang, T. Lackey, R. Klevitsky, et al. 2005. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemiareperfusion-induced cell death in vivo. J. Biol. Chem. 280:32602-32608.
28. Kemi, O. J., M. Ceci, U. Wisloff, S. Grimaldi, P. Gallo, G. L. Smith, et al. 2008. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J. Cell. Physiol. 214:316-321.
29. Kenchaiah, S., J. C. Evans, D. Levy, P. W. Wilson, E. J. Benjamin, M. G. Larson, et al. 2002. Obesity and the risk of heart failure. N. Engl. J. Med. 347:305-313.
30. Kress, A. M., M. C. Hartzel, and M. R. Peterson. 2005. Burden of disease associated with overweight and obesity among U.S. military retirees and their dependents, aged 38-64, 2003. Prev. Med. 41:63-69.
31. Lang, D., A. V. Glukhov, T. Efimova, and I. R. Efimov. 2011. Role of Pyk2 in cardiac arrhythmogenesis. Am. J. Physiol. Heart Circ. Physiol. 301:H975-H983.
32. Laughner, J. I., F. S. Ng, M. S. Sulkin, R. M. Arthur, and I. R. Efimov. 2012. Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. Am. J. Physiol. Heart Circ. Physiol. 303:H753-H765.
33. Lavie, C. J., A. F. Osman, R. V. Milani, and M. R. Mehra. 2003. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am. J. Cardiol. 91:891-894.
34. Liu, W., M. Zi, J. Jin, S. Prehar, D. Oceandy, T. E. Kimura, et al. 2009. Cardiac-specific deletion of Mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth. Circ. Res. 104:905-914.
35. Lopaschuk, G. D., and D. P. Kelly. 2008. Signalling in cardiac metabolism. Cardiovasc. Res. 79:205-207.
36. Mandavia, C. H., L. Pulakat, V. DeMarco, and J. R. Sowers. 2012. Over-nutrition and metabolic cardiomyopathy. Metabolism 61:1205-1210.
37. Marber, M. S., B. Rose, and Y. Wang. 2011. The p38 mitogenactivated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J. Mol. Cell. Cardiol. 51:485-490.
38. McMullen, J. R., T. Shioi, L. Zhang, O. Tarnavski, M. C. Sherwood, P. M. Kang, et al. 2003. Phosphoinositide 3-kinase (p110a) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl Acad. Sci. 100:12355-12360.
39. Mills, E., C. M. Kuhn, M. N. Feinglos, and R. Surwit. 1993. Hypertension in CB57BL/6J mouse model of non-insulindependent diabetes mellitus. Am. J. Physiol. 264:R73-R78.
40. Mosterd, A., and A. W. Hoes. 2007. Clinical epidemiology of heart failure. Heart 93:1137-1146.
41. Nagai, T., T. Anzai, H. Kaneko, Y. Mano, A. Anzai, Y. Maekawa, et al. 2011. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response. Hypertension 57:208-215.
42. Novo, G., D. Guttilla, G. Fazio, D. Cooper, and S. Novo. 2008. The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. Br. J. Clin. Pharmacol. 66:345-351.
43. Oreopoulos, A., R. Padwal, K. Kalantar-Zadeh, G. C. Fonarow, C. M. Norris, and F. A. McAlister. 2008. Body mass index and mortality in heart failure: a meta-analysis. Am. Heart J. 156:13-22.
44. Poelzing, S., and D. S. Rosenbaum. 2004. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am. J. Physiol. Heart Circ. Physiol. 287:H1762-H1770.
45. Raher, M. J., H. B. Thibault, E. S. Buys, D. Kuruppu, N. Shimizu, A. L. Brownell, et al. 2008. A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload. Am. J. Physiol. Heart Circ. Physiol. 295:H2495-H2502.
46. Rockman, H. A., R. S. Ross, A. N. Harris, K. U. Knowlton, M. E. Steinhelper, L. J. Field, et al. 1991. Segregation of atrialspecific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl Acad. Sci. USA 88:8277-8281.
47. Rockman, H. A., S. Ono, R. S. Ross, L. R. Jones, M. Karimi, V. Bhargava, et al. 1994. Molecular and physiological alterations in murine ventricular dysfunction. Proc. Natl Acad. Sci. USA 91:2694-2698.
48. Rose, B. A., T. Force, and Y. Wang. 2010. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90:1507-1546.
49. Shimizu, I., T. Minamino, H. Toko, S. Okada, H. Ikeda, N. Yasuda, et al. 2010. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J. Clin. Investig. 120:1506.
50. Shiojima, I., M. Yefremashvili, Z. Luo, Y. Kureishi, A. Takahashi, J. Tao, et al. 2002. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem. 277:37670-37677.
51. Sopontammarak, S., A. Aliharoob, C. Ocampo, R. A. Arcilla, M. P. Gupta, and M. Gupta. 2005. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy. Cell Biochem. Biophys. 43:61-76.
52. Steinbusch, L. K., J. J. Luiken, R. Vlasblom, A. Chabowski, N. T. Hoebers, W. A. Coumans, et al. 2011. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am. J. Physiol. Endocrinol. Metab. 301: E618-E627.
53. Sundaresan, N. R., P. Vasudevan, L. Zhong, G. Kim, S. Samant, V. Parekh, et al. 2012. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat. Med. 18:1643-1650.
54. Surwit, R. S., C. M. Kuhn, C. Cochrane, J. A. McCubbin, and M. N. Feinglos. 1988. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167.
55. Tuncman, G., J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil. 2006. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl Acad. Sci. 103:10741-10746.
56. Walsh, K. 2006. Akt signaling and growth of the heart. Circulation 113:2032-2034.
57. Wang, Y., B. Su, V. P. Sah, J. H. Brown, J. Han, and K. R. Chien. 1998. Cardiac hypertrophy induced by mitogenactivated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. 273:5423-5426.
58. Weber, M. A., J. M. Neutel, and D. H. Smith. 2001. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J. Am. Coll. Cardiol. 37:169-174.
59. Webster, K. A. 2012. A sirtuin link between metabolism and heart disease. Nat. Med. 18:1617.
60. Wilkins, B. J., Y. S. Dai, O. F. Bueno, S. A. Parsons, J. Xu, D. M. Plank, et al. 2004. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94:110-118.
61. Xia, Y., K. Lee, N. Li, D. Corbett, L. Mendoza, and N. G. Frangogiannis. 2009. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem. Cell Biol. 131:471-481.